Similar modulation by lysosomes on PD-L1 expression has also been reported by Wang et al.23 In addition, we found that GPR84+MDSCs worked as a negative indicator of anti PD-1 therapy in ESCC and NSCLC patients. The gene discussed is CD274; the disease is esophageal squamous cell carcinoma.